RESPIRATORY TRACT INFECTIONS IN CHILDREN
In children up to 3 years of age, upper tract repsiratory infections have a (…)
Pediatrics and Allergology facilities in France, Belgium, Spain and Tunisia aim to evaluate safety and efficacy in the parameters of allergenicity reduction, efficacy in proper development and growth as well as safety of innovative hydrolyzed formulas. Pediatrics and Allergology facilities in France, Belgium, Spain and Tunisia aim to evaluate safety and efficacy in the parameters of allergenicity reduction, efficacy in proper development and growth as well as safety of innovative hydrolyzed formulas.
Proper growth and general well-being acquired toward a relatively common pediatric disorder that impacts the quality of life of the same child and family is one of the goals of current scientific research.